kabutan

Nippon Shinyaku Co.,Ltd.(4516) Summary

4516
TSE Prime
Nippon Shinyaku Co.,Ltd.
5,111
JPY
-49
(-0.95%)
Jan 29, 3:30 pm JST
33.41
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
13.1
PBR
1.33
Yield
2.43%
Margin Trading Ratio
6.79
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
5,060 JPY 33.05 USD
Previous Close Jan 28
5,160 JPY 33.80 USD
High Jan 29, 12:30 pm
5,172 JPY 33.77 USD
Low Jan 29, 9:07 am
4,939 JPY 32.26 USD
Volume
550,600
Trading Value
2.79B JPY 0.02B USD
VWAP
5065.3 JPY 33.11 USD
Minimum Trading Value
511,100 JPY 3,341 USD
Market Cap
0.36T JPY 2.36B USD
Number of Trades
2,177
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
1,431
1-Year High Dec 8, 2025
46,428
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 26,200 120,100 4.58
Jan 16, 2026 35,300 128,300 3.63
Jan 9, 2026 80,400 114,300 1.42
Dec 26, 2025 145,500 121,800 0.84
Dec 19, 2025 162,200 118,200 0.73
Company Profile
Nippon Shinyaku Co., Ltd. primarily focuses on prescription pharmaceuticals, with strengths in urology and cardiovascular fields. The company also operates in the functional food business.
Sector
Pharmaceuticals
Nippon Shinyaku Co., Ltd. centers its operations on the pharmaceutical business, primarily targeting medical professionals, while also expanding into the functional food sector. In the pharmaceutical business, the company manufactures and sells its own products, and its subsidiary, Sioe Pharmaceutical Co., Ltd., also engages in manufacturing and sales. Tajima Food Co., Ltd. manufactures raw materials and supplies them to Nippon Shinyaku. Overseas, the U.S. subsidiary is responsible for pharmaceutical sales, out-licensing, and clinical development, while the Chinese subsidiary provides business support and sales services. In the functional food business, Nippon Shinyaku manufactures and sells its own products, with Tajima Food Co., Ltd. handling contract manufacturing. The company also receives product supplies from Sioe Pharmaceutical Co., Ltd. Furthermore, the subsidiary Nippon Shinyaku Advance Co., Ltd. provides business support, insurance agency services, real estate leasing, and educational support services.